{
  "receipt": "CONT-GRIEF-REG-20261023",
  "review_date": "2026-10-23",
  "classification": "HISTORICAL REASSESSMENT",
  "study": "NCT01179568",
  "doi": "10.1001/jamapsychiatry.2016.0892",
  "registry_source": "https://clinicaltrials.gov/api/v2/studies/NCT01179568",
  "publisher_source": "https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2526240",
  "registry_fields": {
    "startDateStruct.date": "2010-03",
    "studyFirstSubmitDate": "2010-07-14",
    "studyFirstSubmitQcDate": "2010-08-10",
    "studyFirstPostDateStruct": {"date":"2010-08-11","type":"ESTIMATED"},
    "lastUpdatePostDateStruct": {"date":"2017-01-24","type":"ESTIMATED"},
    "primary_outcome_timeFrame": "Weeks 12 and 20"
  },
  "assessment": "Registration was submitted and posted after the reported start of enrolment. This is not prospective registration before enrolment. It predates study completion. The registry dates alone do not establish when individual analysis decisions were made.",
  "publisher_reported_change": "Medication-only primary comparison moved from week 16 to week 12 after the 2011 FDA citalopram dose restriction, in consultation with the data and safety monitoring board.",
  "actual_access": "Current public ClinicalTrials.gov API JSON and selected publisher full-text sections. Original registry version history and full dated protocol not compared. No raw-data or code audit.",
  "novelty": "Newly verified detail in this guide, not new research or a newly released correction.",
  "review_status": "AI-assisted documentary check; independent human methods review pending.",
  "supports_models": [],
  "bq001_status": "UNRESOLVED"
}